CERS Cerus Corporation
Healthcare$2.73+0.74%ClosedMarket Cap: $547.0M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
7.79
P/S
2.44
EV/EBITDA
-42.34
DCF Value
$-0.81
FCF Yield
-0.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
54.3%
Operating Margin
-7.9%
Net Margin
-4.3%
ROE
-15.4%
ROA
-4.3%
ROIC
-10.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $59.9M | 57.0% | $-354.0K | $-1.6M | $— | — |
| Q4 null | $57.8M | 51.5% | $-7.5M | $-2.2M | $— | — |
| FY null | $206.1M | 53.5% | $-36.3M | $-15.6M | $— | — |
| Q3 null | $52.7M | 53.4% | $1.2M | $-19.0K | $— | — |
| Q2 null | $52.4M | 55.2% | $-11.1M | $-5.7M | $— | — |
| Q1 null | $43.2M | 58.8% | $-11.5M | $-7.7M | $— | — |
| Q4 null | $50.8M | 53.9% | $-1.4M | $-2.5M | $— | — |
| FY null | $180.3M | 55.2% | $-14.2M | $-20.9M | $— | — |
| Q3 null | $46.0M | 56.9% | $-961.0K | $-2.9M | $— | — |
| Q2 null | $45.1M | 54.7% | $-3.8M | $-5.8M | $— | — |
| Q1 null | $38.4M | 55.4% | $-8.0M | $-9.7M | $— | — |
| Q4 2023 | $46.8M | 55.5% | $976.0K | $-1.3M | $-0.01 | — |